Tobin & Company Investment Banking Group LLC served as financial advisor and valuation consultant to Physicians Choice Laboratory Services, LLC (PCLS), a rapidly growing toxicology and diagnostic laboratory company navigating a period of substantial industry disruption, operational distress and strategic transition. The engagement involved a series of complex valuation assignments, strategic advisory discussions and fairness analyses during a volatile period in the clinical laboratory industry.
At the time of the engagement, PCLS had evolved into one of the larger laboratories in the prescription compliance monitoring sector, with historical revenues exceeding $150 million annually. However, the company was operating amid severe reimbursement compression, heightened regulatory scrutiny, liquidity constraints and widespread industry instability. Internal strategic planning documents reflected management’s efforts to restructure operations, reduce monthly burn rates, consolidate geographic operations and identify strategic or financial partners capable of stabilizing and recapitalizing the business.
TOBIN was engaged to conduct a detailed fair market valuation of PCLS utilizing guideline public company comparisons, guideline transaction analyses and discounted cash flow methodologies, while also incorporating substantial distress adjustments tied to operational deterioration, tightening liquidity and government investigations impacting the toxicology sector.
The assignment required sophisticated distressed-company analysis. TOBIN evaluated declining sample volumes, negative cash flow trends, strained lender relationships, operational restructuring efforts and substantial regulatory overhang affecting the sector. Internal analytical memoranda documented the firm’s layered valuation framework, including bankruptcy risk assessments, probability-of-distress modeling and modifications to traditional discounted cash flow assumptions in order to reflect the realities of a company operating under significant financial and operational duress.
Beyond the core valuation work, TOBIN also delivered a Fair Value Letter relating to the contemplated transfer and restructuring of CertNDx assets into a newly formed outside entity connected to a departing employee and development partner. The assignment required review of transaction terms, intellectual property acquisitions, projected economics and strategic alternatives in order to determine whether the contemplated transaction represented fair value from a financial perspective to PCLS.
The engagement reflected TOBIN’s broader investment banking capabilities in distressed advisory, healthcare services valuation, strategic alternatives analysis and complex middle-market financial consulting. Throughout the assignment, TOBIN worked closely with ownership and management during a period marked by operational uncertainty, shifting reimbursement paradigms, industry consolidation pressures and active restructuring initiatives.
The work also demonstrated TOBIN’s willingness to tackle difficult and nuanced engagements requiring analytical rigor rather than formulaic valuation exercises. The firm incorporated distressed enterprise valuation theories, including probability-adjusted discounted cash flow methodologies and going-concern risk analyses derived from contemporary valuation scholarship and distressed-market frameworks.
This engagement remains an example of TOBIN’s ability to advise founder-led and middle-market companies facing inflection points requiring sophisticated financial judgment, practical strategic insight and disciplined analytical execution under difficult circumstances.
